Speakers

Thomas Bollenbach

Chief Technology Officer • ARMI

Thomas Bollenbach, Ph.D. is Chief Technology Officer at the Advanced Regenerative Manufacturing Institute (ARMI) and a scientist and project manager at DEKA Research and Development Corp. Prior to joining DEKA, Tom served as Vice President of Research and Development at Harvard Apparatus Regenerative Technology, where he led the development of cell- and biomaterial-based tracheal, bronchial and esophageal implants. Tom joined the HART from Organogenesis, where he implemented and completed IND-enabling preclinical programs for a bioengineered living skin graft, and maintained strong cross-functional interactions with Clinical Operations, Manufacturing and Business Units to provide scientific support to corporate strategies. Tom received his B.Sc. in Biochemistry from the University of Waterloo, a Ph.D. in Biochemistry from the University of Notre Dame, and completed postdoctoral research at Cornell University.

Also Speaking

Emma Bjorgum

Vice President, Client Services, DNA • Aldevron

John Lee

Senior Vice President of Cell Therapy • Center for Breakthrough Medicines

Lili Belcastro

Senior Principal Scientist, Cell and Gene Therapy Raw Materials • Bristol Myers Squibb

Event Info

Image

Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.
Image

Briefings

Find out more and apply to get involved at the briefings taking place at Advanced Therapies Week.